Back to Semaglutide research
semaglutide glp 1 agonist other 2023-11-01 ClinicalTrials

GLP-1 Agonists & CAV-1 Deficiency: A New Angle for Cardiometabolic Health

Role of Caveolin 1 (CAV-1) Deficiency in Response to Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Treatment

Abstract

The Role of Glucagon-like Peptide 1 (GLP-1) Receptor Agonist Treatment of Overweight/Obese Individuals for Improving Adverse Cardiometabolic Phenotype Associated With CAV-1 Deficiency NCT ID: NCT06069622 Status: RECRUITING Sponsor: Brigham…

semaglutide glp 1 agonist
Source: clinicaltrials:NCT06069622 · Ingested 2026-04-03 · Digest: gemini-2.5-flash